Oral Alpan, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

Virginia Commonwealth University School Of Medicine-INOVA Campus - Falls Church VA
Rank: Associate Professor
Years: 2008

None Reported

Inflammasome activation and pyroptosis in lymphopenic liver patients with COVID-19
Journal of Hepatology
Volume: 5
Date: 07 2020

CCR5 Inhibition in Critical COVID-19 Patients Decreases Inflammatory Cytokines, Increases CD8 T-Cells, and Decreases SARS-CoV2 RNA in Plasma by Day 14
international journal of infectious disease
Volume: 10
Date: 11 2020

SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus
Communication in Biology
Volume: 129
Date: 01 2021

Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice
Allergy
76: 242-32
Date: 08 2021

Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS-CoV-2 infection and long COVID
Allergy
Volume: 77
Date: 01 2022

Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies
Frontiers in Immunology
Volume: 21
Date: 02 2022